文献速递主动脉疾病内脏/肾动脉与血管畸形

光纤实时形状传感技术在复杂主动脉腔内修复内脏靶血管插管中的单中心经验

Single Center Experience using Fiber Optic RealShape (FORS) Technology in Patients Treated with Complex Endovascular Aneurysm Repair.
PubMed 文献 · J Endovasc Ther · 2026-08-20

本研究基于前瞻性FORS Learn Registry队列的单中心数据,评估光纤实时形状传感(FORS)在复杂主动脉腔内修复(cEVAR)内脏靶血管插管中的性能与辐射暴露。96例患者共319个内脏靶血管插管,176次FORS尝试的技术成功率为63.6%,成功FORS插管较失败及常规插管显著降低透视时间、剂量面积乘积和空气比释动能,且插管时间最短。

要点

  • FORS在内脏靶血管插管中技术成功率为63.6%,3D-Hub使用后成功率提高。
  • 成功FORS插管显著降低辐射暴露和插管时间。
  • FORS失败转常规插管的结果与直接常规插管相当,支持初始尝试FORS。

核心结论

  • FORS在cEVAR内脏靶血管插管中具有可接受的技术成功率,3D-Hub实施后成功率改善。
  • 成功FORS插管减少辐射暴露和插管时间,失败转常规插管结果与直接常规插管相当。

研究设计与样本

  • 单中心数据来自前瞻性FORS Learn Registry队列研究。
  • 2020年12月至2023年12月,96例患者接受cEVAR,共319个内脏靶血管插管,其中176次FORS尝试。

主要发现

  • FORS技术成功率为63.6%。
  • 开口狭窄靶血管成功率21.7% vs 无狭窄69.9%(P < .001),钙化靶血管14.3% vs 无钙化67.9%(P < .001)。
  • 使用3D-Hub成功率80.6% vs 未使用60.0%(P = .039)。
  • 成功FORS插管透视时间1.7 ± 2.1 min、DAP 3.7 ± 8.5 Gy∙cm2、AK 30.8 ± 55.9 mGy,显著低于FORS失败和常规插管。
  • 成功FORS插管时间6.5 ± 5.0 min,短于常规插管9.7 ± 13.5 min(P = .015)和失败插管14.3 ± 6.9 min(P < .001)。

关键数值与推荐

  • FORS技术成功定义为使用FORS成功插管且未转用常规导丝。
  • 靶血管类型、支架移植物构型或既往靶血管支架不影响技术成功率。

临床怎么用

  • 支持在所有插管中初始尝试FORS以最小化辐射,即使需要转常规插管也不影响结果。
  • 开口狭窄或钙化靶血管FORS成功率较低,使用3D-Hub可提高成功率。

局限性

  • 单中心研究,样本来自特定注册队列。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Fiber Optic RealShape (FORS) is a novel technology using light instead of X-rays to visualize guidewire and catheters during endovascular procedures. A 3D-Hub allows visualization of conventional catheters when used in combination with the FORS guidewire. This study evaluates the FORS performance and radiation exposure during visceral target vessel (TV) catheterization in complex endovascular aortic repair (cEVAR). MATERIALS AND METHODS: Single-centre data were retrieved from the prospective FORS Learn Registry cohort study. The primary outcome was FORS technical success, defined as successful catheterization using FORS without reverting to a conventional guidewire. Secondary outcomes included catheterization and fluoroscopy time, Dose Area Product (DAP) and Air Kerma (AK), compared across technical success, technical failure and conventional catheterizations using analysis of variance (ANOVA) with post hoc testing. RESULTS: Between December 2020 and December 2023, 96 patients underwent cEVAR. In total 319 visceral targets were catheterized, including 176 FORS attempts with a technical success rate of 63.6%. This success rate decreased in TVs with versus without ostial stenosis (21.7% vs 69.9%, P < .001) or with versus without calcification (14.3% vs 67.9%, P < .001), and increased with versus without the use of the 3D-Hub (80.6% vs 60.0%, P = .039). Type of TV, stent graft configuration or prior TV stent did not affect technical success rates. Radiation exposure was significantly lower during successful FORS catheterizations (fluoroscopy time 1.7 ± 2.1 min; DAP 3.7 ± 8.5 Gy∙cm2; AK 30.8 ± 55.9 mGy) compared to FORS technical failures (fluoroscopy time 6.5 ± 4.3 min, P < .001; DAP 8.8 ± 6.4 Gy∙cm2, P = .030; AK 126.5 ± 116.5 mGy, P < .001) and conventional catheterizations (fluoroscopy time 6.2 ± 9.2 min, P < .001; DAP 9.4 ± 20.25 Gy∙cm2, P = .003; AK 111.5 ± 151.1 mGy, P < .001). No significant differences occurred between technically failed and conventional catheterizations. Catheterization time was shortest with FORS technical success (6.5 ± 5.0 min) compared to conventional catheterizations (9.7 ± 13.5 min, P = .015), followed by technical failure (14.3 ± 6.9 min, P < .001). CONCLUSION: Fiber Optic RealShape has an acceptable technical success rate in visceral TV catheterization during cEVAR, which has improved following the 3D-Hub implementation. Successful FORS catheterization results in reduced radiation exposure and catheterization time. When reversion to conventional catheterization is required, outcomes remain comparable to primary conventional procedures, supporting initial FORS use in all catheterizations to minimize radiation. Continued device and software development is essential to optimize FORS performance.Clinical ImpactFiber Optic RealShape (FORS) is a new technology that enables visualization of exclusive FORS-guidewires and catheters using light pulses instead of radiation. This study shows acceptable technical success rates with reduced radiation exposure compared to technically unsuccessful FORS and primary conventional catheterizations of visceral target vessels during complex endovascular aortic repair. These findings support the clinical benefit of initially attempting catheterization with FORS, as it results in reduced radiation exposure, even in case of reversion to conventional devices, without compromising patient outcomes. Additionally, the technical success rates improved significantly following the implementation of the 3D Hub.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Lemmens CC, Mees BME, Vleugels MPJ, et al. Single Center Experience using Fiber Optic RealShape (FORS) Technology in Patients Treated with Complex Endovascular Aneurysm Repair. J Endovasc Ther. 2026. PMID: 42623283. doi:10.1177/15266028261479886

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。